ctrl K

Price Alert

Atossa Therapeutics Inc. (ATOS)

NASDAQ: ATOS · Real-Time Price · USD

0.78

-0.00 (-0.01%)

At close: Aug 15, 2025, 3:59 PM

0.78

-0.04%

After-hours: Aug 15, 2025, 04:10 PM EDT

Atossa Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	71.08M	88.46M	110.89M	136.38M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	1.71M	4.7M	n/a
Other Long-Term Assets	1.99M	2.32M	634K	1K
Receivables	n/a	-1.43M	743K	1.07M
Inventory	n/a	1.49M	5.25M	2.6M
Other Current Assets	229K	110K	110K	-1.29M
Total Current Assets	74.46M	92.22M	118.2M	141.24M
Property-Plant & Equipment	n/a	n/a	n/a	20K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.99M	4.03M	5.33M	22K
Total Assets	76.44M	96.25M	123.53M	141.26M
Account Payables	679K	806K	2.96M	1.72M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	3.04M	1.8M	1.08M	225K
Total Current Liabilities	4.97M	5.24M	5.57M	3.13M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	2.96M	1.72M
Total Liabilities	4.97M	5.24M	5.57M	3.13M
Total Debt	n/a	n/a	n/a	n/a
Common Stock	23.49M	22.79M	22.79M	22.79M
Retained Earnings	-211.79M	-186.29M	-156.19M	-129.23M
Comprehensive Income	n/a	n/a	n/a	-582K
Shareholders Equity	71.48M	91.02M	117.96M	138.14M
Total Investments	n/a	1.71M	4.7M	n/a